珠江钢琴：10月23日召开董事会会议

Group 1 - The core point of the article is that Zhujiang Piano (SZ 002678) held its 39th board meeting on October 23, 2025, where it reviewed the proposal to change its accounting firm [1] - For the first half of 2025, Zhujiang Piano's revenue composition was as follows: Industrial accounted for 82.78%, Property leasing and services for 12.62%, Cultural services for 3.14%, and Other businesses for 1.46% [1] - As of the report date, Zhujiang Piano's market capitalization was 9.3 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have sold overseas licenses worth 80 billion USD this year, highlighting the booming secondary market in biomedicine [1] - A dialogue with Lu Gang, a partner at Chuangdong Investment, indicates that while the secondary market is thriving, the primary market is facing challenges in fundraising [1]